Pharma and Biotech
By Sean Farrell
Date: Thursday 15 Jul 2021
(Sharecast News) - Nuformix's annual loss widened as revenue fell and the pharmaceutical company spent to development its treatments.
By Sean Farrell
Date: Wednesday 10 Feb 2021
(Sharecast News) - Chris Blackwell has quit as Nuformix's chairman a year after taking the job at the drug development company.
By Josh White
Date: Thursday 18 Jul 2019
(Sharecast News) - Nuformix reported total revenue of £0.61m in its final results on Thursday, rising from £0.02m in the prior year, with the company swinging to a gross profit of £0.07m, from a loss of £0.19m.
Currency | UK Pounds |
Share Price | 0.088p |
Change Today | 0.008p |
% Change | 10.00 % |
52 Week High | 0.18p |
52 Week Low | 0.048p |
Volume | 30,672,062 |
Shares Issued | 1,995.71m |
Market Cap | £1.76m |
Beta | 0.04 |
RiskGrade | 322 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:40 | 295,346 @ 0.088p |
16:40 | 1,228 @ 0.088p |
16:40 | 1 @ 0.088p |
16:40 | 294,117 @ 0.088p |
16:03 | 32,022 @ 0.085p |
You are here: research